Journal: Journal of Virology
Article Title: Perturbation of de novo lipogenesis hinders MERS-CoV assembly and release, but not the biogenesis of viral replication organelles
doi: 10.1128/jvi.02282-24
Figure Lengend Snippet: Exogenous palmitic acid supplementation partially rescues MERS-CoV assembly after TOFA treatment. ( A ) Alignment of S and E protein C-terminal sequences from selected coronaviruses using the following accession numbers: MERS-CoV ( NC_019843 ), SARS-CoV ( NC_004718 ), SARS-CoV-2 ( NC_045512 ), MHV ( AY700211 ), TGEV ( AJ271965 ), IBV ( NC_001451 ), and HCoV-229E ( NC_002645.1 ). Cysteines next to the transmembrane domain that can serve as palmitoylation substrates are highlighted in yellow and noted with an asterisk. ( B ) Huh7 cells were infected with MERS -CoV (MOI 5) and treated with either DMSO (vehicle control) or 30 μM 2-BP from 1 h p.i. onward. At 16 h p.i., cell lysates were harvested, and intracellular viral RNA copies were measured by RT-qPCR. ( C ) Infectious viral progeny was quantified by plaque assay on Huh7 cells. Data are represented as mean ± SD of three independent experiments. ( D ) Huh7 cells were infected with MERS-CoV (MOI 5) and treated from 1 h p.i. onward with DMSO supplemented with 100 μM BSA, TOFA, TOFA supplemented with 100 μM BSA-PA, or TOFA supplemented with 100 μM BSA-OA. At 16 h p.i., samples were collected, and infectious viral progeny was quantified by plaque assay on Huh7 cells. Data are represented as mean ± SD of two independent experiments. Statistical significance was calculated using one-way ANOVA and applying Dunnet multiple comparison correction, **** P < 0.0001 and ** P < 0.01, ns: not significant. ( E ) Huh7 cells were infected with MERS-CoV and treated with DMSO, TOFA, or TOFA with BSA-PA from 1 h p.i. onward as previously described, and samples were collected at 12 h p.i. for analysis by Western blotting. Blots are representative of at least two independent biological replicates. ( F-I ) Huh7 cells were infected with MERS-CoV and treated as described above. At 12 h p.i., samples were fixed and processed for TEM. ( F ) Post-addition of palmitic acid, the number of extracellular virus particles present in TOFA-treated virus-infected cells is increased. ( G ) Virions either in the late stage (advanced/fully assembled particles) or early stage were quantified (see Materials and Methods), and the ratio of both classes was determined. ( H ) Number of DMVs per µm 2 of cytoplasm observed (see Materials and Methods) in the DMSO and BSA-treated, TOFA-treated, or TOFA- and BSA-PA-treated virus-infected cells. ( I ) In the same samples, the area of CMs (in nm 2 ) was also determined per µm 2 of cytoplasm (see Materials and Methods). Data are represented as mean ± SD of three separate stiches. Statistical significance was calculated using one-way ANOVA and applying Tukey multiple comparison correction, *** P < 0.001, ** P < 0.01, and * P < 0.05.
Article Snippet: Huh7 cells (kindly provided by Dr. Ralf Bartenschlager, Heidelberg University, Germany) and MRC5 cells (purchased from ATCC, CCL-171) were cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Lonza) supplemented with 8% (v/v) fetal calf serum (FCS), 100 IU/mL penicillin/streptomycin, 2 mM L-glutamine, and non-essential amino acids at 37°C and 5% CO 2 .
Techniques: Infection, Control, Quantitative RT-PCR, Plaque Assay, Comparison, Western Blot, Virus